Literature DB >> 22811544

CD8 marks a subpopulation of lung-derived dendritic cells with differential responsiveness to viral infection and toll-like receptor stimulation.

Nicole M Beauchamp1, Rama D Yammani, Martha A Alexander-Miller.   

Abstract

An increasing number of studies suggest that individual subsets of dendritic cells (DC) exhibit distinct capabilities with regard to the generation of the adaptive immune response. In this study, we evaluated the properties of a relatively unexplored DC subset present in the lung-draining mediastinal lymph node. This subset expresses the airway dendritic cell marker CD103 together with CD8. These DC were of interest given that our previous studies using a model of respiratory infection with vaccinia virus revealed a distinct difference in the ability of CD103(+) DC to prime T cells that correlated inversely with the expression of CD8, suggesting a differential role of these DC in the context of respiratory virus infection. To expand our understanding of the role of this DC population, we performed analyses to elucidate the phenotype, migratory capacity, responsiveness to innate stimuli, and priming capacity of CD8(+) CD103(+) DC. We found that expression of surface markers on these DC was similar to that of CD8(-) CD103(+) DC, supporting their close relationship. Further, the two DC types were similar with regard to antigen uptake. However, although both CD103(+) subsets originated from the lung, CD8-bearing CD103(+) DC appeared in the lymph node with delayed kinetics following virus infection. While this subset exhibited increased responsiveness to a number of Toll-like receptor (TLR) agonists, their response to infection was virus specific, demonstrating poor responsiveness to vaccinia virus infection but robust maturation following infection with parainfluenza virus 5 or influenza virus. These findings show that CD8 marks a population of lung airway-derived DC with distinct migratory and maturation responses that likely contribute differentially to the immune response depending on the infecting pathogen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22811544      PMCID: PMC3457302          DOI: 10.1128/JVI.01413-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Langerhans cells acquire a CD8+ dendritic cell phenotype on maturation by CD40 ligation.

Authors:  F Anjuère; G Martínez del Hoyo; P Martín; C Ardavín
Journal:  J Leukoc Biol       Date:  2000-02       Impact factor: 4.962

2.  A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.

Authors:  A Bowie; E Kiss-Toth; J A Symons; G L Smith; S K Dower; L A O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo.

Authors:  Christopher C Norbury; Daniela Malide; James S Gibbs; Jack R Bennink; Jonathan W Yewdell
Journal:  Nat Immunol       Date:  2002-02-04       Impact factor: 25.606

Review 4.  Poxviruses and immune evasion.

Authors:  Bruce T Seet; J B Johnston; Craig R Brunetti; John W Barrett; Helen Everett; Cheryl Cameron; Joanna Sypula; Steven H Nazarian; Alexandra Lucas; Grant McFadden
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

5.  TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.

Authors:  Ivett Jelinek; Joshua N Leonard; Graeme E Price; Kevin N Brown; Anna Meyer-Manlapat; Paul K Goldsmith; Yan Wang; David Venzon; Suzanne L Epstein; David M Segal
Journal:  J Immunol       Date:  2011-01-17       Impact factor: 5.422

6.  Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection.

Authors:  Nicole M Beauchamp; Rhea Y Busick; Martha A Alexander-Miller
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

7.  The mannose receptor family.

Authors:  Lucy East; Clare M Isacke
Journal:  Biochim Biophys Acta       Date:  2002-09-19

8.  Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB.

Authors:  Camilla T O Benfield; Daniel S Mansur; Laura E McCoy; Brian J Ferguson; Mohammad W Bahar; Asa P Oldring; Jonathan M Grimes; David I Stuart; Stephen C Graham; Geoffrey L Smith
Journal:  J Biol Chem       Date:  2011-04-07       Impact factor: 5.157

9.  Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes.

Authors:  K Y Vermaelen; I Carro-Muino; B N Lambrecht; R A Pauwels
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

10.  The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense.

Authors:  Mary T Harte; Ismar R Haga; Geraldine Maloney; Pearl Gray; Patrick C Reading; Nathan W Bartlett; Geoffrey L Smith; Andrew Bowie; Luke A J O'Neill
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

View more
  8 in total

1.  Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection.

Authors:  Anthony DiPiazza; Katherine Richards; Frances Batarse; Laura Lockard; Hui Zeng; Adolfo García-Sastre; Randy A Albrecht; Andrea J Sant
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

2.  Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells.

Authors:  Frances C Knight; Pavlo Gilchuk; Amrendra Kumar; Kyle W Becker; Sema Sevimli; Max E Jacobson; Naveenchandra Suryadevara; Lihong Wang-Bishop; Kelli L Boyd; James E Crowe; Sebastian Joyce; John T Wilson
Journal:  ACS Nano       Date:  2019-10-04       Impact factor: 15.881

3.  Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response.

Authors:  Mauro Di Pilato; Ernesto Mejías-Pérez; Carlos Oscar S Sorzano; Mariano Esteban
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

4.  IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors:  Allison E Reeme; Halli E Miller; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2013-03-13       Impact factor: 3.131

5.  Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T Cell responses to influenza A virus infection.

Authors:  Christopher Lupfer; Paul G Thomas; Thirumala-Devi Kanneganti
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

6.  Differential involvement of Th1 and Th17 in pathogenic autoimmune processes triggered by different TLR ligands.

Authors:  Guangpu Shi; Barbara P Vistica; Lindsey F Nugent; Cuiyan Tan; Eric F Wawrousek; Dennis M Klinman; Igal Gery
Journal:  J Immunol       Date:  2013-05-29       Impact factor: 5.422

7.  Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy.

Authors:  Kristin L Griffiths; Mushtaq Ahmed; Shibali Das; Radha Gopal; William Horne; Terry D Connell; Kelly D Moynihan; Jay K Kolls; Darrell J Irvine; Maxim N Artyomov; Javier Rangel-Moreno; Shabaana A Khader
Journal:  Nat Commun       Date:  2016-12-22       Impact factor: 14.919

8.  CD31+, CD38+, CD44+, and CD103+ lymphocytes in peripheral blood, bronchoalveolar lavage fluid and lung biopsy tissue in sarcoid patients and controls.

Authors:  Regina Aleksonienė; Justinas Besusparis; Vygantas Gruslys; Laimutė Jurgauskienė; Aida Laurinavičienė; Arvydas Laurinavičius; Radvilė Malickaitė; Jolita Norkūnienė; Rolandas Zablockis; Edvardas Žurauskas; Edvardas Danila
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.